4.7 Article

Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3ζ

Journal

GENES & DEVELOPMENT
Volume 24, Issue 15, Pages 1614-1619

Publisher

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/gad.1942810

Keywords

miR-451; microRNA-451; erythroid differentiation; 14-3-3 zeta; ywhaz; antagomir

Funding

  1. NIH [HL089966, HL09530601A1]
  2. Robert A. Welch Foundation
  3. American Heart Association-Jon Holden DeHaan Foundation

Ask authors/readers for more resources

Erythrocyte formation occurs throughout life in response to cytokine signaling. We show that microRNA-451 (miR-451) regulates erythropoiesis in vivo. Mice lacking miR-451 display a reduction in hematrocrit, an erythroid differentiation defect, and ineffective erythropoiesis in response to oxidative stress. 14-3-3 zeta, an intracellular regulator of cytokine signaling that is repressed by miR-451, is up-regulated in miR-451(-/-) erythroblasts, and inhibition of 14-3-3 zeta rescues their differentiation defect. These findings reveal an essential role of 14-3-3 zeta as a mediator of the proerythroid differentiation actions of miR-451, and highlight the therapeutic potential of miR-451 inhibitors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available